Peer Review History

Original SubmissionJanuary 21, 2026
Decision Letter - Eric Ogola, Editor

-->PONE-D-26-02714-->-->Antibiotic dispensing practices and antimicrobial stewardship gaps in community pharmacies in Kakamega County, Kenya-->-->PLOS One

Dear Dr. Turnbull-Jones,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Kindly address the comments from the two reviewers below

Please submit your revised manuscript by May 15 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Eric Ogola, MPH

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

6. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: 1. Antimicrobial resistance (AMR) remains one of the leading global public health threats,

70 contributing to an estimated 4.95 million deaths in 2019, with the highest burden in sub-

71 Saharan Africa. Please re check for latest data if available as per WHO , or any other valid agencies

2. major thing which is highlighted in conclusion is highlight critical gaps in community antibiotic governance. kindly highlight other important aspects of this study.

Reviewer #2: 1. The research and manuscript is well-structured. The manuscript can be accepted after minor revision since research like this may help to combat the menace of AMR in regions like Kenya.

2. The researchers mentioned in the methodology that they have followed STROBE guidelines for cross-sectional studies. But they have also described the study design as "prospective descriptive cross-sectional ".The design can be "cross-sectional study" since description of the methodology reveals that it is not prospective and since they have employed statistical tests also in interpreting data , the study is should be categorised as "analytical' rather than purely "descriptive".

3. For sampling, they have used consecutive prescription with antibiotic. But they have not provided a relevant justification for the sample "504" and the reason for choosing a particular sampling method.

4. Lines 154 - 155, they mentioned "both". How the dispensing source can be both OTC and prescription-based

5. Lines 178 - 179, they mentioned that few prescriptions had more than one antibiotic. But they did not mention how many prescriptions had two antibiotics, three antibiotics , etc.

6. In methodology and discussion they have included AwARe classification and it is missing in the results. To strengthen analysis, the authors should include the classification.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: Yes: Dr. Saurabh Singh , Ex Professor, School of Pharmaceutical Sciences ,LPU

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

Revision 1

Dear Editors,

Thank you for the opportunity to revise and resubmit our manuscript entitled “Antibiotic dispensing practices and antimicrobial stewardship gaps in community pharmacies in Kakamega County, Kenya.” We are grateful to the editor and reviewers for their constructive and insightful comments, which have helped us to substantially strengthen the manuscript.

We have carefully addressed all editorial and reviewer comments and provide a detailed, point-by-point response below. All changes have been incorporated into the revised manuscript.

Editorial Comments

1. PLOS ONE formatting requirements

We have revised the manuscript to fully comply with PLOS ONE formatting guidelines, including structure, section headings, and file naming conventions. The manuscript has been aligned with the PLOS ONE formatting templates provided.

2. Inclusivity in global research questionnaire

A completed copy of the PLOS ONE inclusivity in global research questionnaire has been included as Supporting Information (S2 File), and this is referenced in the Methods section of the manuscript.

3. Ethics statement placement

The ethics statement has been reviewed and is now included exclusively within the Methods section. It has been removed from any other sections to comply with journal requirements.

4. Funding information consistency

The Funding statement has been reviewed and harmonised across all submission fields. All funding sources are now consistently reported in both the manuscript and submission system. The funding statement now reads, 'This work was supported by the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS), funded by the UK Department of Health and Social Care (DHSC) through the Fleming Fund [project reference: CwPAMS 2.5 A.01], and by Cambridge Global Health Partnerships (CGHP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript'.

5. Supporting Information captions

Captions for all Supporting Information files have been added at the end of the manuscript, and in-text citations have been updated to ensure consistency with PLOS ONE guidelines.

6. Data availability statement

The Data Availability statement has been revised to clarify that the anonymised dataset will be made publicly available in Figshare without restriction upon publication. Data are provided as Supporting Information for peer review.

7. Reviewer-suggested citations

We have reviewed all suggested citations and included relevant references where appropriate. No irrelevant or non-essential citations were added.

8. Reference list accuracy

The reference list has been carefully reviewed and updated to ensure accuracy, completeness, and consistency with in-text citations. No retracted articles are cited.

Reviewer #1

Comment 1: Update AMR mortality data

We have updated the Background section to reflect the most comprehensive available estimates, including both direct (1.27 million) and associated (4.95 million) AMR-related deaths globally in 2019, based on the latest global analysis.

Comment 2: Expand conclusions beyond governance gaps

The Conclusion has been revised to incorporate additional key findings, including:

• Substantial use of broad-spectrum antibiotics across multiple indications

• Financial barriers to completing antibiotic courses

• The central role of pharmacists in antibiotic selection

This provides a more comprehensive summary of the study’s implications.

Reviewer #2

Comment 1: General feedback

We thank the reviewer for their positive assessment of the manuscript.

Comment 2: Study design clarification

The study design has been revised from “prospective descriptive cross-sectional” to “cross-sectional study”, consistent with STROBE guidelines and the analytical nature of the study.

Comment 3: Sampling justification

We have clarified that all eligible dispensing events during the study period were included consecutively to minimise selection bias. We have also stated that a formal sample size calculation was not performed due to the observational design and defined study period.

Comment 4: Clarification of “both” dispensing source

We have clarified that cases classified as “both” refer to instances where a prescription was presented but additional antibiotics were requested and supplied without prescription.

Comment 5: Multiple antibiotics per prescription

We have added detail to the Results section specifying that 52 (10.3%) dispensing events involved more than one antibiotic, most commonly involving two antibiotics, with very few involving three or more.

Comment 6: Inclusion of AWaRe classification in results

We have incorporated the WHO AWaRe classification into the Results section, noting that the majority of antibiotics dispensed belonged to the Access and Watch categories, with frequent use of Watch antibiotics such as macrolides and fluoroquinolones. This has also been further discussed in the Discussion section.

Additional Revisions

In addition to the points raised by reviewers and editors, we have undertaken further refinements to improve clarity and internal consistency:

• Table 2 has been fully revised to ensure accurate, dataset-derived classification of antibiotics by clinical indication using consistent antibiotic class groupings.

• The Results and Discussion sections have been updated to ensure complete alignment with the revised table and underlying dataset.

• Minor language edits have been made throughout to improve clarity, precision, and readability.

We believe these revisions have significantly strengthened the manuscript and addressed all concerns raised during the review process. We are grateful for the opportunity to revise our work and hope it is now suitable for publication in PLOS ONE.

Thank you for your consideration.

Yours sincerely,

Eleanor Turnbull-Jones

(on behalf of all authors)

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Sarah Nanzigu, Editor

Antibiotic dispensing practices and antimicrobial stewardship gaps in community pharmacies in Kakamega County, Kenya

PONE-D-26-02714R1

Dear  Ms Eleanor Rachel Turnbull-Jones,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sarah Nanzigu, Ph.D.,MSc.,MBchB

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: check all grammatical errors and editing mistakes in final manuscript, improve the quality of fig.1, recheck the citations once again

Reviewer #2: review comments addressed. They did not include AWARE category in modifying result. But, they have mentioned about that briefly in discussion

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: Yes: Dr. Saurabh Singh

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Sarah Nanzigu, Editor

PONE-D-26-02714R1

PLOS One

Dear Dr. Turnbull-Jones,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sarah Nanzigu

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .